Welcome to TGR BioSciences
Producing high-value therapeutic products in gastro-intestinal health, skin and tissue repair
Healthcare
TGR BioSciences Pty Ltd (TGR) is a private biotechnology company based
in Adelaide, South Australia. TGR's primary business focus is on the discovery
and development of scientifically proven products that can be marketed
as high-value therapies in oral and gastro-intestinal health, skin and
tissue repair. A lead product is in clinical trials for the prevention
of oral mucositis, the debilitating mouth ulcers that affect over 40%
of all chemotherapy patients and 60% of head-neck radiotherapy patients.
TGR has a number of products in development targeted towards wound repair,
tissue engineering, skin regeneration, and dermatology.
High-throughput Screening & Cell-based
Assay Technologies
TGR has developed leading-edge, cell-based screening technology for high-throughput
discovery of novel bioactives. In addition to the application of this
proprietary technology to our own discovery program, TGR generates revenue
through the sale of SureFire® high throughput assay kits
to biotechnology and pharmaceutical companies through an alliance with
Perkin-Elmer LAS, and by offering bioactive discovery collaborations worldwide.
SUREFIRE is a registered trademark of
TGR BioSciences Pty Ltd, Australia.


